{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:23:52Z","timestamp":1770215032046,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1023\/a:1027328614686","type":"journal-article","created":{"date-parts":[[2003,11,9]],"date-time":"2003-11-09T22:46:39Z","timestamp":1068417999000},"page":"375-379","source":"Crossref","is-referenced-by-count":9,"title":["Low-Dose Systemic Phosphodiesterase III Inhibitor Pimobendan Combined with Prostacyclin Therapy in a Patient with Severe Primary Pulmonary Hypertension"],"prefix":"10.1007","volume":"17","author":[{"given":"Eri","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Kajimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miyoko","family":"Naganuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kasanuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5149506_CR1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ,Rubin LJ,Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.","journal-title":"N Engl J Med"},{"key":"5149506_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","volume":"336","author":"LJ. Rubin","year":"1997","unstructured":"Rubin LJ. Primary pulmonary hypertension. N Engl JMed 1997; 336: 111-117.","journal-title":"N Engl JMed"},{"key":"5149506_CR3","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S1053-2498(02)00498-9","volume":"21","author":"MI Hertz","year":"2002","unstructured":"Hertz MI,Taylor DO,Trulock EP, et al. The registry of the International Society for Heart and Lung Transplantation: Nineteenth official report-2002. J Heart Lung Transplant 2002; 21: 950-970.","journal-title":"J Heart Lung Transplant"},{"key":"5149506_CR4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1161\/01.CIR.95.6.1479","volume":"95","author":"AL Hinderliter","year":"1997","unstructured":"Hinderliter AL,Willis IV PW,Barst RJ, et al. for the Primary Pulmonary Hypertension Study Group. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997; 95: 1479-1486.","journal-title":"Circulation"},{"key":"5149506_CR5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/hrt.70.4.366","volume":"70","author":"T Higenbottam","year":"1993","unstructured":"Higenbottam T,Spiegelhalter D,Scott JP, et al. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J 1993; 70: 366-370.","journal-title":"Br Heart J"},{"key":"5149506_CR6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.RES.68.3.689","volume":"68","author":"M Boumlhm","year":"1991","unstructured":"Boumlhm M,Morano I,Pieske B, et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res 1991; 68: 689-701.","journal-title":"Circ Res"},{"key":"5149506_CR7","doi-asserted-by":"crossref","first-page":"L536","DOI":"10.1152\/ajpcell.1994.266.2.C536","volume":"266","author":"KF Rabe","year":"1994","unstructured":"Rabe KF,Tenor H,Dent G,Schudt C,Nakashima M,Magnussen H. Identification of PDE isozymes in human pulmonary artery and effect of selective PDE inhibitors. Am J Physiol 1994; 266: L536-L543.","journal-title":"Am J Physiol"},{"key":"5149506_CR8","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0735-1097(96)00399-3","volume":"28","author":"M Givertz","year":"1996","unstructured":"Givertz M,Hare J,Loh E,Gauthier D,Colucci W. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: A rapid test for reversibility of pulmonary hypertension. J AmColl Cardiol 1996; 28: 1775-1780.","journal-title":"J AmColl Cardiol"},{"key":"5149506_CR9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1053-2498(98)00070-9","volume":"18","author":"SV Pamboukian","year":"1999","unstructured":"Pamboukian SV,Carere RG,Webb JG, et al. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension. J Heart Lung Transplant 1999; 18: 367-371.","journal-title":"J Heart Lung Transplant"},{"key":"5149506_CR10","doi-asserted-by":"crossref","first-page":"L1361","DOI":"10.1152\/ajplung.2001.281.6.L1361","volume":"281","author":"RT Schermuly","year":"2001","unstructured":"Schermuly RT,Roehl A,Weissmann N, et al. Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2001; 281: L1361-L1368.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"5149506_CR11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1164\/ajrccm.160.5.9901102","volume":"160","author":"RT Schermuly","year":"1999","unstructured":"Schermuly RT,Ghofrani HA,Enke B, et al. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension. Am J Respir Crit Care Med 1999; 160: 1500-01506.","journal-title":"Am J Respir Crit Care Med"},{"key":"5149506_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1164\/ajrccm.157.2.9708012","volume":"157","author":"TJ. Trophy","year":"1998","unstructured":"Trophy TJ. Phosphodiesterase isozymes: Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998; 157: 351-370.","journal-title":"Am J Respir Crit Care Med"},{"key":"5149506_CR13","first-page":"847","volume":"35","author":"Y Yamazaki","year":"1997","unstructured":"Yamazaki Y,Matsumoto H,Takeda A, et al. Effects of pimobendan on pulmonary hypertension in patients with chronic pulmonary emphysema. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35: 847-853 (in Japanese with English abstract).","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"5149506_CR14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","volume":"343","author":"S Prasad","year":"2000","unstructured":"Prasad S,Wilkinson J,Gatzoulis MA. Sildenafil in primary pulmonary hypertension. N Engl J Med 2000; 343: 1342.","journal-title":"N Engl J Med"},{"key":"5149506_CR15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/hc3601.096826","volume":"104","author":"H Wilkens","year":"2001","unstructured":"Wilkens H,Guth A,Konig J, et al. Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 2001; 104: 1218-1222.","journal-title":"Circulation"},{"key":"5149506_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","volume":"136","author":"HA Ghofrani","year":"2002","unstructured":"Ghofrani HA,Wiedemann R,RoseF, et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136: 515-522.","journal-title":"Ann Intern Med"},{"key":"5149506_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1054\/jcaf.2001.24609","volume":"7","author":"A. Maisel","year":"2001","unstructured":"Maisel A. B-Type natriuretic peptide levels: A potential novel \u201cwhite count\u201d for congestive heart failure. J Card Fail 2001; 7: 183-193.","journal-title":"J Card Fail"},{"key":"5149506_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","volume":"31","author":"N Nagaya","year":"1998","unstructured":"Nagaya N,Nishikimi T,Okano Y, et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208.","journal-title":"J Am Coll Cardiol"},{"key":"5149506_CR19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","volume":"102","author":"N Nagaya","year":"2000","unstructured":"Nagaya N,Nishikimi T,Uematsu M, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-870.","journal-title":"Circulation"},{"key":"5149506_CR20","first-page":"591","volume":"13","author":"H Hayashi","year":"1992","unstructured":"Hayashi H,Nakajima M,Tanahashi Y, et al. Clinical evaluation of pimobendan (UD-CG 115 BS) on acute heart failure-Dose finding study for a multicenter double-blind group comparison-. Ther Res 1992; 13: 591-612 (in Japanese with English abstract).","journal-title":"Ther Res"},{"key":"5149506_CR21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00005344-200006000-00011","volume":"35","author":"R Ishiki","year":"2000","unstructured":"Ishiki R,Ishihara H,Izawa H,Nagata K,Hirai M,Yokota M. Acute effects of a single low dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failure. J Cardiovasc Pharmacol 2000; 35: 897-905.","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1027328614686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1027328614686\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1027328614686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:09:58Z","timestamp":1751051398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1027328614686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["5149506"],"URL":"https:\/\/doi.org\/10.1023\/a:1027328614686","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}